New York State Psychiatric Institute
3 clinical trials · 3 recruiting · OTHER
Trials by New York State Psychiatric Institute
RECRUITINGPhase 4NCT05208190
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
Two-hundred and eighty individuals with schizophrenia who have a recent history of violent acts will be randomized in this 2-arm, parallel-group, 24-week, open-label, 7-site...
Sponsor: New York State Psychiatric InstituteEnrolling: 2807 locations
SchizophreniaSchizoaffective Disorder
RECRUITINGPhase 2 / Phase 3NCT05011266
Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
This study will evaluate the effectiveness of a new pharmacological approach to increase efficacy of treatment with extended release naltrexone (XR-naltrexone) for individuals...
Sponsor: New York State Psychiatric InstituteEnrolling: 1802 locations
Opioid-use Disorder
RECRUITINGPhase 2NCT05999240
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
This Phase 2 study examines the safety, tolerability, and preliminary efficacy of pimavanserin in individuals with Autism Spectrum Disorder. Male or female participants aged 12 to...
Sponsor: New York State Psychiatric InstituteEnrolling: 302 locations
Autism Spectrum Disorder